The World Health Organization (WHO) has recommended the use of GLP-1-based medications, such as Ozempic and Wegovy, in the treatment of obesity, emphasizing that they should be combined with a healthy diet, physical exercise, and medical monitoring. WHO has urged pharmaceutical companies to reduce prices and expand production to make these therapies accessible even in low-income countries. Although these medications are already well established in developed countries, WHO warns that global access remains limited, estimating that by 2030, less than 10% of people who could benefit from them will have access.
The new WHO therapeutic guideline includes a conditional recommendation for the use of GLP-1, considering the limited data on long-term efficacy and safety. WHO suggests differentiated pricing and voluntary licenses to allow other manufacturers to produce these medications. The expiration of patents for semaglutide, the active ingredient in Ozempic and Wegovy, will allow the emergence of generic medications, which could reduce prices. However, logistical challenges and the need to prepare health systems for the distribution of these medications remain significant obstacles.
The new WHO therapeutic guideline includes a conditional recommendation for the use of GLP-1, considering the limited data on long-term efficacy and safety. WHO suggests differentiated pricing and voluntary licenses to allow other manufacturers to produce these medications. The expiration of patents for semaglutide, the active ingredient in Ozempic and Wegovy, will allow the emergence of generic medications, which could reduce prices. However, logistical challenges and the need to prepare health systems for the distribution of these medications remain significant obstacles.
Sources
Latest News
17:46
Mirabela Grădinaru participates in the international conference “Their Future. Our Responsibility,” held in Warsaw
17:40
Croatia Risks Reduction in Final RRF Payment After Commission Identifies Three Unfulfilled Milestones and Targets
17:35
The CCR rejected Nicușor Dan’s referral and declared the amendments to the normative act on hunting and the protection of hunting grounds constitutional.
17:28
Julio Iglesias is under investigation in Spain after two former employees accused him of sexual assault and degrading treatment
17:20
Education unions criticize the draft regarding student enrollment numbers for 2027–2028 and call for a return to the class sizes stipulated in Law 198/2023
See more news